<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H13FB468A13334756A63337F214E6EE9E" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 4071 IH: Foreign Gain-of-Function Research Prevention Act of 2021</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2021-06-22</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 4071</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20210622">June 22, 2021</action-date><action-desc><sponsor name-id="W000815">Mr. Wenstrup</sponsor> (for himself, <cosponsor name-id="B001291">Mr. Babin</cosponsor>, <cosponsor name-id="G000565">Mr. Gosar</cosponsor>, <cosponsor name-id="D000628">Mr. Dunn</cosponsor>, <cosponsor name-id="J000302">Mr. Joyce of Pennsylvania</cosponsor>, <cosponsor name-id="J000304">Mr. Jackson</cosponsor>, <cosponsor name-id="M001215">Mrs. Miller-Meeks</cosponsor>, <cosponsor name-id="S001192">Mr. Stewart</cosponsor>, <cosponsor name-id="C001087">Mr. Crawford</cosponsor>, <cosponsor name-id="C001103">Mr. Carter of Georgia</cosponsor>, <cosponsor name-id="S001196">Ms. Stefanik</cosponsor>, and <cosponsor name-id="N000181">Mr. Nunes</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To prohibit the use of Federal funds to conduct or support certain gain-of-function research by a foreign adversary.</official-title></form><legis-body id="H531E85B7BB4B4F7AA6362791CF6BC12C" style="OLC"><section id="HFD7D8EC9546543F9A94B1DAA703CCB8F" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Foreign Gain-of-Function Research Prevention Act of 2021</short-title></quote>.</text></section><section id="HA8E14AEB5576495C96B7728C5235F506"><enum>2.</enum><header>Prohibition on Federal funding for certain gain-of-function research by a foreign adversary</header><subsection id="HEECA936504754ED68915AE3420094361"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">No Federal funds may be made available, whether directly or indirectly, or used by an entity, to conduct or support any gain-of-function research involving a potential pandemic pathogen by a foreign adversary, including—</text><paragraph id="H3BCD354CA58446ACA46D07206B3BB1D1"><enum>(1)</enum><text>China, Russia, Iran, and North Korea; and</text></paragraph><paragraph id="H6D194976D1634A04B0300E48BE880887"><enum>(2)</enum><text>any other country the Secretary of State, in consultation with the Secretary of Defense, the Director of National Intelligence, or any other appropriate Federal official, determines to be a foreign adversary for the purposes of this section.</text></paragraph></subsection><subsection id="H0654EA46DCDA4AC0AE830BD7313B335F"><enum>(b)</enum><header>Funding freeze for violations</header><text>Any entity the Secretary of State finds to have used Federal funds in violation of this section may not receive any Federal funding for a period of 5 years, beginning on the date of such finding.</text></subsection><subsection id="H5625CC5A12224EEABD557C395E4C2341"><enum>(c)</enum><header>Definitions</header><text display-inline="yes-display-inline">In this section:</text><paragraph id="H5E2A35059ABB4108878A8B4702CBB534"><enum>(1)</enum><header>Gain-of-function research</header><text>The term <quote>gain-of-function research</quote> means any research that may be reasonably anticipated to confer an attribute to a pathogen such that the pathogen would have enhanced pathogenicity or transmissibility in mammals.</text></paragraph><paragraph id="HC3E42CEDF71D4A379F3BB2CEDE2F64B6"><enum>(2)</enum><header>Potential pandemic pathogen</header><text>The term <quote>potential pandemic pathogen</quote> means a pathogen that, prior to any gain-of-function research—</text><subparagraph id="H05D496AC9DA5430AA347C95FA66E74C2"><enum>(A)</enum><text>is likely highly transmissible and likely capable of wide and uncontrollable spread in human populations; and</text></subparagraph><subparagraph id="H56AF0AF8BB9B49E9BB5CA434DA275179"><enum>(B)</enum><text>is likely highly virulent and likely to cause significant morbidity or mortality in humans.</text></subparagraph></paragraph></subsection></section></legis-body></bill> 

